WHO ICTRP trial
Early Phase 2 Clinical Study of JTS-661 - Efficacy and Safety Study -
JPRN-jRCT2080223725 · Japan Primary Registries Network (JPRN)
Key facts
| Trial ID | JPRN-jRCT2080223725 |
|---|---|
| Public title | Early Phase 2 Clinical Study of JTS-661 - Efficacy and Safety Study - |
| Scientific title | Early Phase 2 Clinical Study of JTS-661 - Efficacy and Safety Study - |
| Primary sponsor | JAPAN TABACCO INC. |
| Registry | Japan Primary Registries Network (JPRN) |
| Study type | Interventional |
| Phase | 2 |
| Conditions | Pruritus |
| Interventions | investigational material(s) Generic name etc : JTS-661 INN of investigational material : Serlopitant Therapeutic category code : 449 Other antiallergic agents Dosage and Administration for Investigational material : Oral |
| Registration date | Nov 21, 2017 |
| Target size | 240 |
| Secondary IDs | JapicCTI-173781 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: